{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T18:10:23Z","timestamp":1683137423361},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1984,3,1]],"date-time":"1984-03-01T00:00:00Z","timestamp":446947200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Springer Semin Immunopathol"],"published-print":{"date-parts":[[1984,3]]},"DOI":"10.1007\/bf01891778","type":"journal-article","created":{"date-parts":[[2005,7,5]],"date-time":"2005-07-05T07:21:22Z","timestamp":1120548082000},"page":"35-42","source":"Crossref","is-referenced-by-count":3,"title":["Immunosuppressant therapy of idiopathic thrombocytopenic purpura"],"prefix":"10.1007","volume":"7","author":[{"given":"Yeon S.","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindra","family":"Mylvaganam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01891778_CR1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev.me.28.020177.001503","volume":"28","author":"YS Ahn","year":"1977","unstructured":"Ahn YS, Harrington WJ (1977) Treatment of idiopathic thrombocytopenic purpura. Annu Rev Med 28: 299","journal-title":"Annu Rev Med"},{"key":"BF01891778_CR2","first-page":"453","volume":"25","author":"YS Ahn","year":"1980","unstructured":"Ahn YS, Harrington WJ (1980) Clinical use of macrophage inhibitors. Adv Intern Med 25: 453","journal-title":"Adv Intern Med"},{"key":"BF01891778_CR3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1056\/NEJM197408222910802","volume":"291","author":"YS Ahn","year":"1974","unstructured":"Ahn YS, Harrington WJ, Seelman RC, Eytel C (1974) Vincristine therapy of idiopathic and secondary thrombocytopenias. N Engl J Med 291: 376","journal-title":"N Engl J Med"},{"key":"BF01891778_CR4","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJM197805182982001","volume":"298","author":"YS Ahn","year":"1978","unstructured":"Ahn YS, Byrnes JJ, Harrington WJ, Cayer ML, Smith DS, Brunskill DE, Pall LM (1978) The treatment of idiopathic thrombocytopenia with vinblastine-loaded platelets. N Engl J Med 298:1101","journal-title":"N Engl J Med"},{"key":"BF01891778_CR5","first-page":"795a","volume":"26","author":"YS Ahn","year":"1978","unstructured":"Ahn YS, Harrington WJ, Byrnes JJ, Pestana JB (1978) Slow infusion vinca alkaloids in the treatment of refractory ITP. Clin Res 26: 795a","journal-title":"Clin Res"},{"key":"BF01891778_CR6","doi-asserted-by":"crossref","unstructured":"Ahn YS, Harrington WJ, Mylvaganam R, Allan LM, Pall LM (to be published) Slow infusion of vinca alkaloids in treatment of idiopathic thrombocytopenic purpura. Ann Intern Med","DOI":"10.7326\/0003-4819-100-2-192"},{"key":"BF01891778_CR7","doi-asserted-by":"crossref","unstructured":"Ahn YS, Harrington WJ, Simon SR, Mylvaganam R, Pall LM, So AG (1983) The use of danazol in idiopathic thrombocytopenia purpura. N Engl J Med","DOI":"10.1056\/NEJM198306093082306"},{"key":"BF01891778_CR8","unstructured":"Ahn YS, Harrington WJ, Mylvaganam R, Chua L, Otoya J, Pall LM. Danazol therapy restores helper\/suppressor (T4\/T8) ratios in patients with idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia Blood 62 (suppl) 1983 (in press)"},{"key":"BF01891778_CR9","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1056\/NEJM198210283071816","volume":"307","author":"P Bierling","year":"1982","unstructured":"Bierling P, Farcet JP, Dvedari N (1982) Gammaglobulin for idiopathic thrombocytopenic purpura. N Engl J Med 307: 1150","journal-title":"N Engl J Med"},{"key":"BF01891778_CR10","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM196609222751202","volume":"275","author":"BA Bouroncle","year":"1966","unstructured":"Bouroncle BA, Doan CA (1966) Refractory idiopathic thrombocytopenic purpura treated with Imuran. N Engl J Med 275: 630","journal-title":"N Engl J Med"},{"key":"BF01891778_CR11","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0140-6736(78)90800-0","volume":"1","author":"RE Branda","year":"1978","unstructured":"Branda RE, Tate DY, McCullough JJ, Jacob HS (1978) Plasma exchange in the treatment of fulminant (autoimmune) thrombocytopenic purpura. Lancet 1: 688","journal-title":"Lancet"},{"key":"BF01891778_CR12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/0002-9610(75)90197-X","volume":"129","author":"MF Brennan","year":"1975","unstructured":"Brennan MF, Rappaport JM, Moloney WC, Wilson RE et al. (1975) Correlation between response to corticosteroids and splenectomy for adult idiopathic thrombocytopenic purpura. Am J Surg 129:490","journal-title":"Am J Surg"},{"key":"BF01891778_CR13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJM198009043031003","volume":"303","author":"CV Broome","year":"1980","unstructured":"Broome CV, Facklam RR, Fraser DW (1980) Pneumococcal disease after pneumococcal vaccination: alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med 303: 549","journal-title":"N Engl J Med"},{"key":"BF01891778_CR14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(58)90057-6","volume":"275","author":"EJ Watson-Williams","year":"1958","unstructured":"Watson-Williams EJ, Macpherson AIS, Davidson S (1958) Treatment of idiopathic thrombocytopenic purpura. Lancet 275: 221","journal-title":"Lancet"},{"key":"BF01891778_CR15","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1001\/jama.1959.03010320001001","volume":"171","author":"AF Carpenter","year":"1959","unstructured":"Carpenter AF, Wintrobe MM, Fuller EA, Haut A, Cartwright G (1959) Treatment of idiopathic thrombocytopenic purpura. JAMA 171: 1911","journal-title":"JAMA"},{"key":"BF01891778_CR16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJM196109282651301","volume":"265","author":"P Cohen","year":"1961","unstructured":"Cohen P, Gardner FH (1961) Thrombocytopenic effect of sustained high-dosage prednisone therapy in thrombocytopenic purpura. N Engl J Med 265: 611","journal-title":"N Engl J Med"},{"key":"BF01891778_CR17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0002-9343(80)90016-9","volume":"69","author":"SM Defino","year":"1980","unstructured":"Defino SM, Lachant NA, Kirshner JJ, Gottlieb AJ (1980) Adult idiopathic thrombocytopenic purpura. Clinical findings and response to therapy. Am J Med 69: 430","journal-title":"Am J Med"},{"key":"BF01891778_CR18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7326\/0003-4819-53-5-861","volume":"53","author":"CA Doan","year":"1960","unstructured":"Doan CA, Bouroncle BA, Wiseman BK (1960) Idiopathic and secondary thrombocytopenic purpura: clinical study and evaluation of 381 cases over a period of 28 years. Ann Intern Med 53: 861","journal-title":"Ann Intern Med"},{"key":"BF01891778_CR19","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1056\/NEJM198205273062102","volume":"306","author":"J Fehr","year":"1982","unstructured":"Fehr J, Hoffman V, Kappeler U (1982) Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high dose intravenous gammaglobulin. N Engl J Med 306: 1254","journal-title":"N Engl J Med"},{"key":"BF01891778_CR20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(74)90745-1","volume":"56","author":"SC Finch","year":"1974","unstructured":"Finch SC, Castro O, Cooper M, Covey W, Erichson R, McPhedran P (1974) Immunosuppressive therapy of chronic idiopathic thrombocytopenic purpura. Am J Med 56: 4","journal-title":"Am J Med"},{"key":"BF01891778_CR21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1542\/peds.27.5.689","volume":"27","author":"M Finland","year":"1961","unstructured":"Finland M (1961) Serious infections in splenectomized children. Pediatrics 27: 689","journal-title":"Pediatrics"},{"key":"BF01891778_CR22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2141.1970.tb01605.x","volume":"19","author":"LA Harker","year":"1970","unstructured":"Harker LA (1970) Thrombokinetics in idiopathic thrombocytopenic purpura. Br J Haematol (1916) 19: 95","journal-title":"Br J Haematol"},{"key":"BF01891778_CR23","unstructured":"Harrington WJ, Ahn YS. Unpublished observations"},{"key":"BF01891778_CR24","series-title":"Henry Ford Hosp. Symp. Blood platelets","first-page":"659","volume-title":"Immune reactions of platelets","author":"WJ Harrington","year":"1961","unstructured":"Harrington WJ, Arimura G (1961) Immune reactions of platelets. Henry Ford Hosp. Symp. Blood platelets. Little Brown, Boston, p 659"},{"key":"BF01891778_CR25","unstructured":"Harrington WJ, Halloran MJ (1960) Studies on steroid binding by mammaliam platelets. Proc VIII Intern Congr Hematol 1960, p 1750"},{"key":"BF01891778_CR26","first-page":"1","volume":"38","author":"WJ Harrington","year":"1951","unstructured":"Harrington WJ, Minnich V, Hollingsworth JW, Moore CV (1951) Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 38: 1","journal-title":"J Lab Clin Med"},{"key":"BF01891778_CR27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/0003-4819-38-3-433","volume":"38","author":"WJ Harrington","year":"1953","unstructured":"Harrington WJ, Sprague CC, Minnich V, Moore CV, Ahlvin R, Dubach R (1953) Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura. Ann Intern Med 38: 433","journal-title":"Ann Intern Med"},{"key":"BF01891778_CR28","first-page":"166","volume":"1","author":"WJ Harrington","year":"1956","unstructured":"Harrington WJ, Minnich V, Arimura G (1956) The autoimmune thrombocytopenias. Prog Hematol 1: 166","journal-title":"Prog Hematol"},{"key":"BF01891778_CR29","first-page":"186a","volume":"60","author":"WJ Harrington","year":"1982","unstructured":"Harrington WJ, Ahn YS, So AG, Ayub J, Simon S, Pall LM (1982) Danazol therapy of autoimmune thrombocytopenias. Blood 60: 186a","journal-title":"Blood"},{"key":"BF01891778_CR30","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","volume":"1","author":"P Imbach","year":"1981","unstructured":"Imbach P, Barandum S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Sch\u00f6ni M, Vest M, Wagner HP (1981) High dose intravenous gamma-globulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1: 1228","journal-title":"Lancet"},{"key":"BF01891778_CR31","first-page":"482A","volume":"31","author":"RP Junghans","year":"1983","unstructured":"Junghans RP, Ahn YS, Mylvaganam R (1983) High dose intravenous gammaglobulin to suppress alloimmune destruction of donor platelets. Clin Res 31: 482A","journal-title":"Clin Res"},{"key":"BF01891778_CR32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1182\/blood.V56.3.329.329","volume":"56","author":"S Karpatkin","year":"1980","unstructured":"Karpatkin S (1980) Autoimmune thrombocytopenic purpura. Blood 56: 329","journal-title":"Blood"},{"key":"BF01891778_CR33","first-page":"1451","volume":"29","author":"P Kaznelson","year":"1916","unstructured":"Kaznelson P (1916) Verschwinden der h\u00e4morrhagischen Diathese bei einem Falle von \u201eessentieller Thrombopenie\u201d (Frank) nach Milzextirpation. Splenogene thrombolytische purpura. Wien Klin Wochenschr 29: 1451","journal-title":"Wien Klin Wochenschr"},{"key":"BF01891778_CR34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/jama.1971.03180160045011","volume":"215","author":"RK Laros","year":"1971","unstructured":"Laros RK, Penner JA (1971) \u201cRefractory\u201d thrombocytopenia purpura treated successfully with cyclophosphamide. JAMA 215: 445","journal-title":"JAMA"},{"key":"BF01891778_CR35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1537-2995.1981.21381201800.x","volume":"21","author":"VJ Marder","year":"1981","unstructured":"Marder VJ, Nusbacher J, Anderson FW (1981) One year follow-up of plasma exchange therapy in 14 patients with thrombocytopenic purpura. Transfusion 21: 291","journal-title":"Transfusion"},{"key":"BF01891778_CR36","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJM198105073041904","volume":"304","author":"R McMillan","year":"1981","unstructured":"McMillan R (1981) Chronic idiopathic thrombocytopenic purpura. N Engl J Med 304: 1135","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"BF01891778_CR37","first-page":"200A","volume":"58","author":"J Melo","year":"1981","unstructured":"Melo J, Harrington WJ, Ahn YS, Collin AS (1981) Colchicine therapy of idiopathic thrombocytopenic purpura (ITP). Blood 58 (Suppl 1): 200A","journal-title":"Blood"},{"key":"BF01891778_CR38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00000441-196109000-00004","volume":"242","author":"MC Meyers","year":"1961","unstructured":"Meyers MC (1961) Results of treatment in 71 patients with idiopathic thrombocytopenic purpura. Am J Med Sci 242: 295","journal-title":"Am J Med Sci"},{"key":"BF01891778_CR39","first-page":"229","volume":"52","author":"JP Michalski","year":"1983","unstructured":"Michalski JP, McCombs CC, Roubinian JR, Talal N (1983) Effect of androgen therapy on survival and suppressor cell activity in aged NZB\/NZW Fl hybrid mice. Clin Exp Immunol 52: 229","journal-title":"Clin Exp Immunol"},{"key":"BF01891778_CR40","first-page":"287","volume":"308","author":"C Mueller-Eckhardt","year":"1983","unstructured":"Mueller-Eckhardt C, Kuenzlen E, Thilo-Korner D, Thilo-K\u00f6rner, Pralle H (1983) High-dose intravenous immunoglobulin for post-transfusion purpura. N Engl J Med 308: 287","journal-title":"N Engl J Med"},{"key":"BF01891778_CR41","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/bmj.2.4686.971","volume":"2","author":"HN Robson","year":"1950","unstructured":"Robson HN, Duthie JJR (1950) Capillary resistance and adrenocortical activity. Br Med J 2: 971","journal-title":"Br Med J"},{"key":"BF01891778_CR42","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1749-6632.1965.tb18984.x","volume":"124","author":"NR Shulman","year":"1965","unstructured":"Shulman NR, Marder VJ, Weinrach RS (1965) Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic thrombocytopenic purpura: physiologic, serologic, and isotopic studies. Ann NY Acad Sci 124: 499","journal-title":"Ann NY Acad Sci"},{"issue":"Suppl 1","key":"BF01891778_CR43","first-page":"193A","volume":"60","author":"SV Strother","year":"1982","unstructured":"Strother SV, Zuckerman KS, LoBuglio AF (1982) Colchicine therapy of refractory immune thrombocytopenia. Blood 60 (Suppl 1): 193A","journal-title":"Blood"},{"key":"BF01891778_CR44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jama.1967.03130170059006","volume":"202","author":"LN Sussman","year":"1967","unstructured":"Sussman LN (1967) Azathioprine in refractory idiopathic thrombocytopenic purpura. JAMA 202: 259","journal-title":"JAMA"},{"key":"BF01891778_CR45","first-page":"380","volume":"132","author":"RC Thompson","year":"1972","unstructured":"Thompson RC, Moore RA, Hess CE, Wheby MS, Leavell BS (1972) Idiopathic thrombocytopenic purpura: long-term results of treatment and the prognostic significance of response to corticosteroids. Arch Intern Med 132: 380","journal-title":"Arch Intern Med"},{"key":"BF01891778_CR46","first-page":"442","volume":"53","author":"CN Verheyden","year":"1978","unstructured":"Verheyden CN, Beart RW, Lifton MD, Phyliky RL (1978) Accessory splenectomy in management of recurrent idiopathic thrombocytopenic purpura. Mayo Clin Proc 53: 442","journal-title":"Mayo Clin Proc"},{"key":"BF01891778_CR47","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.2830010111","volume":"1","author":"M Verlin","year":"1976","unstructured":"Verlin M, Laros RK, Penner J (1976) Treatment of refractory thrombocytopenic purpura with cyclophosphamide. Am J Hematol 1: 97","journal-title":"Am J Hematol"},{"key":"BF01891778_CR48","first-page":"419","volume":"234","author":"JJ Viala","year":"1975","unstructured":"Viala JJ, Dechavanne M, Ville D (1975) Les \u00e9preuves radioisotopiques plaquetaires permettent-elles de meilleures indications de la spl\u00e9nectomie au cours du purpura thrombop\u00e9nique idiopathique chronique? A propos de 50 observations. Lyon Med 234: 419","journal-title":"Lyon Med"},{"key":"BF01891778_CR49","first-page":"1100","volume":"16","author":"B Weinerman","year":"1974","unstructured":"Weinerman B, Maxwell I, Hryniuk W (1974) Intermittent cyclosphamide treatment of autoimmune thrombocytopenia. Can Med Assoc J 16: 1100","journal-title":"Can Med Assoc J"}],"container-title":["Springer Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01891778.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01891778\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01891778","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T17:45:30Z","timestamp":1683135930000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01891778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,3]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1984,3]]}},"alternative-id":["BF01891778"],"URL":"https:\/\/doi.org\/10.1007\/bf01891778","relation":{},"ISSN":["0344-4325","1432-2196"],"issn-type":[{"value":"0344-4325","type":"print"},{"value":"1432-2196","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,3]]}}}